Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Anzalone Christopher Richard Create: Alert

All | News | Filings
Date FiledTypeDescription
05/05/2023 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 54,928 shares @ $39.14, valued at $2.1M
Sold 24,008 shares @ $38.97, valued at $935.6k
Sold 25,992 shares @ $40.02, valued at $1M
Exercised 54,928 options to buy @ $2.01, valued at $110.4k
Exercised 50,000 options to buy @ $2.01, valued at $100.5k
12/20/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 18,375 shares @ $0
Granted 234,025 shares @ $0
09/29/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 39,082 shares @ $30.77, valued at $1.2M
Exercised 1,542 shares @ $31.21, valued at $48.1k
07/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 40,853 shares @ $53.11, valued at $2.2M
Sold 42,153 shares @ $52.28, valued at $2.2M
Sold 61,482 shares @ $50.9, valued at $3.1M
Sold 1,900 shares @ $50.51, valued at $96k
Exercised 146,388 options to buy @ $5.19, valued at $759.8k
01/07/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 11,806 options to buy @ $5.19, valued at $61.3k
01/04/2022 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 800,000 shares @ $0
12/23/2021 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 11,806 options to buy @ $5.19, valued at $61.3k
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/22/2021 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 15,000 shares @ $66.23, valued at $993.5k
Sold 44,170 shares @ $65.57, valued at $2.9M
Sold 5,830 shares @ $66.09, valued at $385.3k
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/30/2020 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Gifted 1,126 shares @ $0
12/22/2020 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 12,236 options to buy @ $4.75, valued at $58.1k
Exercised 28,274 options to buy @ $6.15, valued at $173.9k
12/10/2020 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 16,324 shares @ $67.97, valued at $1.1M
Sold 16,726 shares @ $67.27, valued at $1.1M
Sold 12,067 shares @ $69.8, valued at $842.3k
Sold 5,880 shares @ $70.87, valued at $416.7k
Sold 4,003 shares @ $71.61, valued at $286.7k
Exercised 16,324 options to buy @ $2.01, valued at $32.8k
Exercised 38,676 options to buy @ $2.01, valued at $77.7k
10/23/2020 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 87,728 shares @ $58.16, valued at $5.1M
Sold 12,272 shares @ $58.57, valued at $718.8k
08/14/2020 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 50,000 shares @ $41.35, valued at $2.1M
Exercised 50,000 options to buy @ $9.9, valued at $495k
06/26/2020 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 99,977 shares @ $38.81, valued at $3.9M
Sold 23 shares @ $39.55, valued at $909.7
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/27/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 23,219 shares @ $66.82, valued at $1.6M
Sold 58,059 shares @ $67.31, valued at $3.9M
Sold 10,343 shares @ $68.51, valued at $708.6k
Sold 8,379 shares @ $69.41, valued at $581.6k
Sold 8,951 shares @ $65.85, valued at $589.4k
Sold 45,577 shares @ $66.47, valued at $3M
Sold 25,412 shares @ $67.3, valued at $1.7M
Sold 3,393 shares @ $68.18, valued at $231.3k
12/04/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 5,743 shares @ $66.58, valued at $382.4k
Sold 7,193 shares @ $67.63, valued at $486.5k
Sold 8,510 shares @ $68.5, valued at $582.9k
Sold 6,617 shares @ $69.5, valued at $459.9k
Sold 2,448 shares @ $70.72, valued at $173.1k
Sold 3,800 shares @ $72.13, valued at $274.1k
Sold 3,656 shares @ $72.95, valued at $266.7k
Sold 4,011 shares @ $60.73, valued at $243.6k
Sold 8,022 shares @ $62, valued at $497.4k
10/11/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 56,325 shares @ $31.83, valued at $1.8M
Exercised 56,325 options to buy @ $5.2, valued at $292.9k
09/27/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 20,000 shares @ $28.25, valued at $565k
09/24/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 4,250 shares @ $29, valued at $123.3k
Sold 41,755 shares @ $29.04, valued at $1.2M
Sold 53,972 shares @ $28, valued at $1.5M
Sold 12,673 shares @ $29.04, valued at $368k
Exercised 4,250 options to buy @ $5.1, valued at $21.7k
Exercised 41,755 options to buy @ $5.1, valued at $213k
Exercised 66,645 options to buy @ $5.1, valued at $339.9k
05/29/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Exercised 40,072 options to buy @ $2.01, valued at $80.5k
Exercised 9,376 options to buy @ $2.62, valued at $24.6k
04/05/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 50,000 shares @ $19.3, valued at $965k
01/03/2019 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Granted 600,000 shares @ $0
12/21/2018 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 90,000 shares @ $13.92, valued at $1.3M
12/14/2018 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 90,000 shares @ $14.07, valued at $1.3M
11/09/2018 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 76,200 shares @ $14.35, valued at $1.1M
Sold 5,300 shares @ $14.95, valued at $79.2k
09/05/2018 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 100,000 shares @ $14.45, valued at $1.4M
Sold 64,834 shares @ $14.45, valued at $936.9k
03/16/2018 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 26,000 shares @ $7.4, valued at $192.4k
03/15/2018 4 Anzalone Christopher Richard (CEO) has filed a Form 4 on ARROWHEAD PHARMACEUTICALS, INC.
Txns: Sold 100,000 shares @ $7.43, valued at $743k
Sold 100,000 shares @ $7.44, valued at $744k
Sold 100,000 shares @ $7.41, valued at $741k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy